Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MSCI vs GSK✓SelectedUSD · GSKMSCI vs GSK performance historyLatest closeAs of-4.20%11/17
Stock and ETF performance explorer

MSCI vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+15.7%
GSK return
+7.1%
Excess return
+8.6%
Maximum drawdown
-18.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-4.2%-2.3%-1.9%-4.1%
7D-2.8%-3.0%+0.2%-2.7%
30D+12.2%+0.4%+11.9%+12.2%
3M+16.0%-1.2%+17.2%+15.8%
6M+14.1%+0.9%+13.2%+14.6%
YTD+12.5%+4.0%+8.6%+12.3%
1Y+15.7%+7.3%+8.4%+15.4%
All+15.7%+7.1%+8.6%+15.4%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling